During Tuesday’s Google I/O keynote, Demis Hassabis, the CEO of Google DeepMind, proclaimed that we are currently “standing ...

Drugs that were once hailed as possible breakthroughs in the battle to treat Alzheimer’s have no meaningful clinical effect on the disease’s progression, a new Cochrane review found. Cochrane reviews ...

The U.S. Food and Drug Administration is seeking to accelerate the review process for three companies that are studying psilocybin and an MDMA-like drug as treatments for depression and PTSD ...

Ambitious research is on the chopping block following yet more cuts at the National Science Foundation. This past week delivered another gut punch for science in the US. This time, the target was the ...

Mr. Singal is writing a book about the debate over youth gender medicine in the United States and writes the newsletter Singal-Minded. See more of our coverage in your search results.Encuentra más de ...